Stockscreener 앱 받기
5.10%
시장 영업 전:
전일 마감가:
$1.57
열려 있는:
$1.6
하루 거래량:
15.64M
Relative Volume:
0.87
시가총액:
$1.06B
수익:
$183.88M
순이익/손실:
$-85.78M
주가수익비율:
-12.82
EPS:
-0.1287
순현금흐름:
$-110.95M
1주 성능:
+9.27%
1개월 성능:
-0.60%
6개월 성능:
+51.38%
1년 성능:
+16.20%
1일 변동 폭
$1.57
$1.66
1주일 범위
$1.48
$1.66
52주 변동 폭
$1.04
$2.01
제론 Stock (GERN) Company Profile
명칭
Geron Corp
전화
(650) 473-7700
주소
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Compare GERN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.65 | 1.06B | 183.88M | -85.78M | -110.95M | -0.1287 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
제론 Stock (GERN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 재개 | Goldman | Sell |
| 2025-05-08 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2025-02-27 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2025-02-26 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | 개시 | H.C. Wainwright | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-09-09 | 개시 | Leerink Partners | Outperform |
| 2024-04-30 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | 개시 | TD Cowen | Buy |
| 2024-03-15 | 재확인 | Needham | Buy |
| 2023-09-12 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-03-28 | 개시 | Goldman | Neutral |
| 2022-10-28 | 개시 | Wedbush | Outperform |
| 2022-07-28 | 재개 | B. Riley Securities | Buy |
| 2021-11-02 | 개시 | Robert W. Baird | Outperform |
| 2021-02-18 | 재개 | B. Riley Securities | Buy |
| 2020-08-03 | 개시 | Stifel | Buy |
| 2019-11-19 | 재개 | B. Riley FBR | Buy |
| 2019-09-03 | 개시 | H.C. Wainwright | Buy |
| 2019-08-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-04-09 | 업그레이드 | Needham | Hold → Buy |
| 2019-01-31 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | 개시 | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | 재확인 | FBR & Co. | Outperform |
| 2016-09-13 | 재확인 | FBR Capital | Outperform |
| 2015-12-07 | 재확인 | Piper Jaffray | Overweight |
| 2015-04-21 | 개시 | Oppenheimer | Outperform |
| 2014-06-12 | 업그레이드 | MLV & Co | Hold → Buy |
| 2014-03-12 | 다운그레이드 | MLV & Co | Buy → Hold |
| 2013-12-10 | 재확인 | MLV & Co | Buy |
| 2013-12-10 | 업그레이드 | Needham | Hold → Buy |
| 2013-11-08 | 재확인 | MLV & Co | Buy |
| 2013-10-16 | 개시 | MLV & Co | Buy |
| 2012-08-30 | 개시 | Stifel Nicolaus | Buy |
| 2012-06-28 | 개시 | Needham | Hold |
모두보기
제론 주식(GERN)의 최신 뉴스
MSN Money - MSN
Geron earnings loom: Can RYTELO revenue sustain commercial momentum? By Investing.com - Investing.com Canada
Geron executives line up two healthcare investor conference talks - Stock Titan
Geron Plans to Present at Upcoming Investor Conferences - Yahoo Finance
Earnings Preview: Geron to Report Financial Results Pre-market on May 06 - 富途牛牛
GERN News | GERON CORP (NASDAQ:GERN) - ChartMill
Geron (GERN) to Release Earnings on Wednesday - MarketBeat
Geron (NASDAQ:GERN) Stock Price Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat
Geron Corporation (GERN) Appoints Timothy Williams as EVP, Chief Legal Officer - Insider Monkey
GERN Technical Analysis | Trend, Signals & Chart Patterns | GERON CORP (NASDAQ:GERN) - ChartMill
Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026 - ChartMill
Geron sets May 6 financial update with webcast before market open - Stock Titan
GERN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Form 4Statement of changes in beneficial ownership of securities - ADVFN
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - ChartMill
Geron (NASDAQ:GERN) Stock Price Down 5.1%Here's What Happened - MarketBeat
Nine new Geron hires receive options at $1.68 a share - Stock Titan
Geron Corporation (NASDAQ:GERN) Short Interest Up 21.3% in March - MarketBeat
Geron Corporation (NASDAQ:GERN) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Geron (GERN) grants 2.5M stock options to chief legal officer - Stock Titan
Geron (GERN) EVP and Chief Legal Officer files initial Form 3 insider report - Stock Titan
Geron Adds Chief Legal Officer As Equity Ties To Execution Risk - Yahoo Finance
Geron Corp stock (US3741631036): Is imetelstat approval the real test for biotech upside? - AD HOC NEWS
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Geron Highlights RYTELO Launch, 2026 Revenue Outlook and Phase 3 Myelofibrosis Plans at Needham Conf - MarketBeat
Geron names Timothy Williams as chief legal officer By Investing.com - Investing.com South Africa
Geron names Timothy Williams as chief legal officer - Investing.com
Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary - ChartMill
Geron Corp stock (US3741631036): Is imetelstat approval the real test for biotech investors now? - AD HOC NEWS
History Review: Can Geron Corporation be the next market leader2026 Key Lessons & Risk Managed Investment Signals - baoquankhu1.vn
GERN Stock Grinds Sideways As Traders Watch Biotech Breakout Levels - StocksToTrade
GERN Stock Price, Quote & Chart | GERON CORP (NASDAQ:GERN) - ChartMill
Aberdeen Group plc Boosts Stock Holdings in Geron Corporation $GERN - MarketBeat
Board agenda in new Geron (NASDAQ: GERN) 2026 virtual annual meeting proxy - Stock Titan
Geron Corporation (GERN) stock price, news, quote and history - Yahoo Finance UK
Geron Corporation (GERN) Stock Price, News, Quote & History - Yahoo! Finance Canada
[ARS] GERON CORP SEC Filing - Stock Titan
Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference - The Manila Times
GERN’s Strategic Moves Signal Strong Market Confidence - timothysykes.com
Is Geron (GERN) Quietly Reframing Its Oncology Commercialization Strategy With New Board Appointments? - simplywall.st
Geron (NASDAQ:GERN) Trading Up 9.7%What's Next? - MarketBeat
Geron Corporation’s Strategic Moves Amplify Stocks in Q1 2026 - StocksToTrade
Market Recap: Can Geron Corporation deliver consistent dividendsPortfolio Performance Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Geron (NASDAQ:GERN) Share Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
Aug Highlights: Can Geron Corporation be the next market leaderExit Point & Breakout Confirmation Trade Signals - baoquankhu1.vn
Geron Corp Stock: Biotech Investor Focus on RYTELO Commercialization and Valuation Gap Amid Market V - AD HOC NEWS
Geron Adds Biopharma Veterans As RYTELO Focus And Valuation Draw Attention - Yahoo Finance
GERN SEC FilingsGeron Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Geron Corporation Form 8-K Filing Details for March 25, 2026: Company Information, Stock Symbol, and SEC Compliance 16 - Minichart
Vanguard (NASDAQ: GERN) discloses 0 share ownership after realignment - Stock Titan
Geron (NASDAQ: GERN) director granted 270,000 stock options at $1.57 strike - Stock Titan
제론 (GERN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):